ADC Therapeutics SA annual net debt
2018
2019
2020
2021
2022
2023
2024
2025
ADC Therapeutics SA Net Debt Growth & History (ADCT)
ADC Therapeutics SA's net debt was −$256.8M for fiscal 2025.
View full ADC Therapeutics SA company overviewADC Therapeutics SA annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$256.8M | −$15.3M | — |
| 2024 | 2024-12-31 | −$241.5M | $25.4M | — |
| 2023 | 2023-12-31 | −$267.0M | $31.7M | — |
| 2022 | 2022-12-31 | −$298.6M | $66.1M | — |
| 2021 | 2021-12-31 | −$364.8M | $32.5M | — |
| 2020 | 2020-12-31 | −$397.3M | −$286.8M | — |
| 2019 | 2019-12-31 | −$110.5M | $22.9M | — |
| 2018 | 2018-12-31 | −$133.4M | — | — |
ADC Therapeutics SA quarterly net debt
Q4.19
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$212.0M | $49.5M | — |
| Q1 2026 | 2026-03-31 | −$225.4M | −$40.0M | — |
| Q4 2025 | 2025-12-31 | −$256.8M | −$15.3M | — |
| Q3 2025 | 2025-09-30 | −$232.7M | $31.2M | — |
| Q2 2025 | 2025-06-30 | −$261.5M | $27.9M | — |
| Q1 2025 | 2025-03-31 | −$185.4M | $37.8M | — |
| Q4 2024 | 2024-12-31 | −$241.5M | $25.4M | — |
| Q3 2024 | 2024-09-30 | −$263.9M | $20.7M | — |
| Q2 2024 | 2024-06-30 | −$289.4M | $31.9M | — |
| Q1 2024 | 2024-03-31 | −$223.2M | $75.0M | — |
| Q4 2023 | 2023-12-31 | −$267.0M | $31.7M | — |
| Q3 2023 | 2023-09-30 | −$284.6M | $88.8M | — |
| Q2 2023 | 2023-06-30 | −$321.3M | −$47.8M | — |
| Q1 2023 | 2023-03-31 | −$298.1M | $30.2M | — |
| Q4 2022 | 2022-12-31 | −$298.6M | $66.1M | — |
| Q3 2022 | 2022-09-30 | −$373.4M | $56.1M | — |
| Q2 2022 | 2022-06-30 | −$273.5M | −$1.0M | — |
| Q1 2022 | 2022-03-31 | −$328.3M | $7.0M | — |
| Q4 2021 | 2021-12-31 | −$364.8M | $32.5M | — |
| Q3 2021 | 2021-09-30 | −$429.5M | — | — |
| Q2 2021 | 2021-06-30 | −$272.4M | — | — |
| Q1 2021 | 2021-03-31 | −$335.3M | — | — |
| Q4 2020 | 2020-12-31 | −$397.3M | −$286.8M | — |
| Q4 2019 | 2019-12-31 | −$110.5M | — | — |
ADC Therapeutics SA net debt trends
Over the last five fiscal years, ADC Therapeutics SA's net debt increased from −$397.3M to −$256.8M, a change of $140.6M. The latest reported quarter, Q2 2026, shows −$212.0M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ADC Therapeutics SA source filings ↗